title: The Ongoing Evolution of Optimal Clinical Endpoints for Heart Failure Trials.
authors.affiliation: Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address: henry.krum@med.monash.edu.au.
authors.forename: Henry
authors.initials: H
authors.lastname: Krum
authors.affiliation: Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
authors.forename: Ingrid
authors.initials: I
authors.lastname: Hopper
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002303:Cardiac Output, Low / Q000188:drug therapy* / Q000401:mortality*; D002423:Cause of Death / Q000639:trends*; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality*; D006801:Humans
chemical_list: D000319:Adrenergic beta-Antagonists
keywords: beta-blockers; clinical trials; endpoints; mortality